Trial Profile
A Single-center, Placebo-controlled, Randomized, Double-blind, Parallel-group Comparison Trial to Assess the Safety and Pharmacokinetics of OPA-15406 Ointment in Healthy Adult Male Subjects (Phase 1 Trial)
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 05 Oct 2016
Price :
$35
*
At a glance
- Drugs Difamilast (Primary)
- Indications Atopic dermatitis
- Focus Adverse reactions
- Sponsors Otsuka Pharmaceutical
- 12 Aug 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 09 Jan 2015 New trial record